Storia della carriera di Jürgen Beck
Precedenti posizioni note di Jürgen Beck
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PAION AG | Corporate Officer/Principal | 01/01/2018 | 31/12/2020 |
| InterMune International AG | Corporate Officer/Principal | - | - |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Amministratore Delegato | - | - |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Direttore Tecnico/Scientifico/R&S | 01/12/2015 | - |
| EPIGENOMICS AG | Direttore Tecnico/Scientifico/R&S | 01/01/2010 | - |
Formazione di Jürgen Beck
| Julius-Maximilians-Universität Würzburg | Undergraduate Degree |
| Humboldt-Universität zu Berlin | Undergraduate Degree |
| University of Hagen | Masters Business Admin |
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 8 |
| Belgio | 2 |
| Svizzera | 2 |
Posizioni
| Undergraduate Degree | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EPIGENOMICS AG | Health Technology |
| PAION AG | Health Technology |
| Aziende private | 3 |
|---|---|
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
| InterMune International AG |
- Borsa valori
- Insiders
- Jürgen Beck
- Esperienza
